North American Industry Classification System (NAICS) as biotechnology firms to estimate several Fama-French three factor …In the current study we find that biotechnology firms are exposed to greater financial risk than other industries and … capital over the 1982-2005 time period were 16.25 percent for biotechnology firms. Of course, these average estimates obscure …

We analyze how variations in contractibility affect the design of contracts in the context of biotechnology research … agreements. A major concern of firms financing biotechnology research is that the R&D firms might use the funding to subsidize … maintaining broad property rights to the terminated project. The option right induces the biotechnology firm researchers not to …

Using detailed data on biotechnology in Japan, we find that identifiable collaborations" between particular university …

which are threatened by persistent low performance. While all incumbent firms lagged the dedicated new biotechnology firms …

profound, biotechnology applications in this large incumbent firm are more likely to be combined with other techno- logies than … in the new biotechnology firms (NBFs) which use biotechnology for both discovery and production of new therapeutic … more effective applications of the new technologies, but it could retard full adoption of biotechnology. It appears that …

The local academic science base plays a dominant role in determining where and when biotechnology is adopted by … pharmaceutical business -- biotechnology's most important application -- the performance enhancement associated with this … biotechnology, with the latter playing a somewhat larger role. De nova entry was determined similarly as if entry and organizational …

This paper investigates the local impact of biomedical research on mortality in the USA. Causally estimating the …